Segmented information (Tables)

12 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Schedule of segment reporting information based on geography

The Company recognizes segmentation based on geography as follows:

Year ended December 31, 2019	Europe		Rest of World		Total
Revenue	$	22,425	$	10,209	$	32,634
Cost of goods sold		7,170		2,657		9,827
Gross margin		15,255		7,552		22,807
Gross margin %		68%		74%		70%

Year ended December 31, 2018	Europe		Rest of World		Total
Revenue	$	16,165	$	12,509	$	28,674
Cost of goods sold		5,466		2,828		8,294
Gross margin		10,699		9,681		20,380
Gross margin %		66%		77%		71%

Year ended December 31, 2017	Europe		Rest of World		Total
Revenue	$	10,953	$	13,055	$	24,008
Cost of goods sold		2,974		3,802		6,776
Gross margin		7,979		9,253		17,232
Gross margin %		73%		71%		72%

Summary of revenues disaggregated by source

The following table presents the Company’s revenues disaggregated by revenue source:

Year ended December 31,	2019		2018		2017
Cardiology	$	19,358	$	22,497	$	22,753
Antibiotic		13,276		6,177		1,255
	$	32,634	$	28,674	$	24,008